Today: 20 May 2026
OCBC stock price slips after Bank of Singapore names new CFO; investors watch earnings next month
19 January 2026
1 min read

OCBC stock price slips after Bank of Singapore names new CFO; investors watch earnings next month

Singapore, January 19, 2026, 14:56 SGT — Regular session

  • OCBC shares dipped during afternoon trading
  • Bank of Singapore appointed OCBC executive Collins Chin as its new global CFO
  • All eyes now turn to OCBC’s full-year results, due out next month

OCBC (SGX:O39) shares slipped Monday after naming Collins Chin, currently an OCBC executive, as global CFO of its private-banking arm, Bank of Singapore, effective immediately. By 2:48 p.m. Singapore time, the stock had fallen 0.49% to S$20.34, trading between S$20.27 and S$20.38 earlier, close to its 52-week peak of S$20.54.

The stock hovers close to the high end of its one-year range, a level where minor news often triggers profit-taking. The big event ahead is full-year earnings next month, with investors keen to see details on dividends and capital strategy.

Bank of Singapore runs the group’s private-banking division, which zeroes in on wealth management for high-net-worth clients. Fee income here moves with market ups and downs. Hiring a finance professional won’t immediately lift profits, but it signals the unit’s intent to clamp down on costs, sharpen controls, and push for growth.

Chin takes over from Ho Soo Woon, who left in 2025 after 14 years, the Business Times reports. CEO Jason Moo called the change “a testament to the commitment of OCBC Group to nurture homegrown talent,” according to the article. The Business Times

Shares of larger rival DBS gained about 0.9%, and UOB edged higher too, leaving OCBC in the dust among the local banking trio today.

Investors are less concerned with job changes and more fixated on key metrics: net interest margin — the difference between what a bank earns on loans and what it pays out on deposits — plus any shifts in bad-loan provisions. Fees linked to wealth management and markets also swing, providing a sharp indicator of how the private bank is perceived.

OCBC announced a S$2.5 billion capital return plan last year, which includes special dividends and share buybacks spread over two years. The upcoming earnings season will reveal how much of that plan is still in play and whether the bank will stick to its current pace.

With the rally pulling ahead, there’s little room left to maneuver. Should rates drop sooner than anticipated or regional credit conditions change, margins might shrink quickly, forcing companies to rethink their generous payouts.

OCBC is set to announce its full-year 2025 results on Feb. 25.

Stock Market Today

  • Stock Market Today May 20: Nasdaq Rises 1.5% on Renewed Risk Appetite
    May 20, 2026, 5:43 PM EDT. The S&P 500 gained 1.08% to 7,432.97, Nasdaq rose 1.54% to 26,270.36, and Dow advanced 1.31% to 50,009.34 amid falling oil prices and easing Treasury yields. AI hardware stocks like AMD and Super Micro Computer led gains, with Nvidia up 1.3% before its earnings report. Software names Salesforce and CrowdStrike also recovered. Hasbro declined nearly 9% despite beating earnings forecasts due to cautious guidance. Investor optimism reflects hopes for an end to the U.S.-Iran conflict, lowering West Texas Intermediate crude by 5% to $99 a barrel. Nvidia's earnings beat was met with muted reaction as investors awaited stronger sales forecasts. The Motley Fool highlighted other top stock picks, noting Nvidia and Netflix's historic outperformance over the S&P 500.

Latest articles

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
Amkor stock (AMKR) slips before holiday reopen as insider sale notice surfaces
Previous Story

Amkor stock (AMKR) slips before holiday reopen as insider sale notice surfaces

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks
Next Story

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks

Go toTop